Find News

Filter articles

Showing 61 to 70 of 2294 results

MHRA seizes fake medicine worth more than £2m


The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

Novartis and Pfizer sign clinical development agreement


Swiss pharmaceutical company Novartis has partnered with Pfizer, its American rival, in efforts to advance the treatment of non-alcoholic steatohepatitis.

Allergan and tribe ask for stay pending SCOTUS appeal


Allergan and the Saint Regis Mohawk Tribe have urged the US Court of Appeals for the Federal Circuit to stay its ruling against them pending an appeal to the US Supreme Court.

J&J reveals plans to appeal cancer drug court ruling


Johnson & Johnson has revealed its intention to appeal against a district court’s invalidation of a patent covering its prostate cancer drug Zytiga (abiraterone acetate).

FDA improves generic approval rate under Trump: report


The US Food and Drug Administration’s generic drug approval rate has increased at a “rapid rate” since January 2017, despite the number of branded drug patent expirations declining during this period.

Interpol seizes 500 tonnes of illicit pharmaceuticals

International, US26-10-2018

More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday.

Nelson Mullins adds life sciences litigator in NYC


Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel.

USITC to review Fujifilm breast imaging case


The US International Trade Commission yesterday announced that it will review in-part the final initial determination of an investigation into Fujifilm involving X-ray breast imaging.

Duane Morris names IP lawyer as pharma litigation chair


Duane Morris has appointed Patrick Gallagher as chair of the firm’s pharmaceuticals and biopharmaceuticals litigation and regulatory practice group.

EU General Court dismisses Bayer’s Aspirin trademark appeal


Trademarks covering Bayer’s branded Aspirin were at the centre of an appeal dismissed by the EU General Court yesterday.

Showing 61 to 70 of 2294 results